GlassScriptPhysician profile
Megan Indermaur
NPI 1780697870
$85,920.95
in general payments reported to CMS, 2019-2025
47 companies · $4,676 in 2025
The $4,676 reported for 2025 was more than what 86% of Gynecologic Oncology providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30K · 2020: $11K · 2021: $19K · 2022: $10K · 2023: $3,249 · 2024: $7,525 · 2025: $4,676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,760 · Food and Beverage: $3,806 · Education: $1,606 · Consulting Fee: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,760.00 |
| Food and Beverage | $3,805.87 |
| Education | $1,606.05 |
| Consulting Fee | $277.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $70,735.74 | 2019-2025 | Lynparza |
| Baxter Healthcare | $7,573.67 | 2019-2025 | Coseal, Tisseel, Floseal |
| Aspira Women'S Health INC | $3,421.96 | 2019 | |
| Intuitive Surgical, INC. | $842.18 | 2021-2024 | Da Vinci Surgical System |
| Merck Sharp & Dohme LLC | $375.58 | 2019-2025 | Lynparza, Keytruda |
| Eisai INC. | $366.48 | 2019-2025 | |
| Caris Mpi, INC. | $291.71 | 2025 | Mi Cancer Seek |
| Abbvie INC. | $287.43 | 2020-2025 | |
| Glaxosmithkline, LLC. | $264.60 | 2020-2024 | Jemperli, Zejula |
| Ethicon US, LLC | $150.51 | 2021-2025 | Vistaseal, Ethicon, Surgicel Nu-Knit |
| Immunogen, INC. | $133.88 | 2024 | Elahere |
| Medical Device Business Services, INC. | $123.03 | 2021 | |
| Tersera Therapeutics LLC | $108.70 | 2019 | |
| Integra Lifesciences Corporation | $106.94 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Tempus Ai, INC | $105.66 | 2024-2025 | Xt Cdx |
Show all 46 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Indermaur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.